ArticleAmerican journal of translational research2022
Systematic evaluation of cell-free insulin DNA levels in early blood glucose testing as a predictor of postpartum hypertension in pregnant women with gestational diabetes mellitus.
Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the perinatal outcome of postpartum hypertension in pregnant women with gestational diabetes (GDM).
methodsA total of 100 puerperae who gave birth in our hospital from March 2018 to January 2020 were retrospectively analyzed. Among them, 50 patients were puerperae with postpartum hypertension (experimental group), and 50 puerperae had normal postpartum blood pressure (control group). Before delivery, fasting, postprandial and bedtime blood glucose, glycosylated hemoglobin, and urine glucose were compared between the two groups.
resultsBefore delivery, the experimental group observed significantly higher fasting, postprandial, and bedtime blood glucose, glycosylated hemoglobin, and urine glucose than the control group (P<0.05). A notable decline in natural delivery rate was witnessed in the experimental group (P<0.05). The two groups presented no significant differences in neonatal outcomes, neonatal blood glucose and blood pressure, maternal blood pressure at 30 weeks and 34 weeks of pregnancy, and blood lipid levels during pregnancy (P>0.05).
conclusionPostpartum hypertension in pregnant women with GDM results in a low probability of natural birth and it has a slight impact on the fetus.
Indexed as
Identifiers
35836844PMC9274557W4285612029What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.